ARK Genomic Revolution ETF
ARKG
292 hedge funds and large institutions have $666M invested in ARK Genomic Revolution ETF in 2023 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 59 increasing their positions, 103 reducing their positions, and 32 closing their positions.
6% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 32
2% less funds holding
Funds holding: 297 → 292 (-5)
3.54% less ownership
Funds ownership: 34.5% → 30.96% (-3.5%)
13% less call options, than puts
Call options by funds: $33.7M | Put options by funds: $38.8M
43% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 103
71% less capital inflows, than outflows
Capital inflows: $33.9M | Capital outflows: $118M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$8.73M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$4.25M |
| 3 |
Quantitative Investment Management
Charlottesville,
Virginia
|
+$3.16M |
| 4 |
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$1.84M |
| 5 |
BlueCrest Capital Management
St Helier,
Jersey
|
+$1.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$27.3M |
| 2 |
Morgan Stanley
New York
|
-$24.9M |
| 3 |
Goldman Sachs
New York
|
-$24.7M |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$8.96M |
| 5 |
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$5.97M |
ARKG Hedge Fund Activity: Q2 2023 in Review
292 of the 6,391 institutional investors tracked by Wall St. Rank reported a position in ARK Genomic Revolution ETF (ARKG) for Q2 2023, worth a combined $666M — down 0.5% from $669M a quarter earlier.
Sellers outnumbered buyers: 32 funds closed out of ARKG and 30 opened new positions — a net loss of 2 holders — while 103 trimmed existing stakes and 59 added.
The largest buyer was Wells Fargo, adding an estimated $8.73M. The largest seller was Bank of America, cutting an estimated $27.3M.
- 292 institutional investors held ARK Genomic Revolution ETF (ARKG) as of Q2 2023, down from 297 in Q1 2023.
- Funds reported $666M of ARK Genomic Revolution ETF stock for Q2 2023, down 0.5% quarter-over-quarter.
- 30 funds opened new ARK Genomic Revolution ETF positions in Q2 2023 and 32 closed out, a net change of -2 holders.
- The largest ARK Genomic Revolution ETF buyer in Q2 2023 was Wells Fargo, an estimated $8.73M added.
- The largest ARK Genomic Revolution ETF seller in Q2 2023 was Bank of America, an estimated $27.3M sold.
Based on aggregated 13F filings for Q2 2023.